Images
Participants
Contact
Several media have echoed research by IRB Barcelona researcher Travis H. Stracker on the key role of the TLK2 gene for the development of the placenta and for embryo viability in mice.
Published in the journal Cell Death and Differentiation, this finding may be of biomedical relevance. A recent massive genomics study of people with intellectual disabilities performed in the Netherlands points to TLK2 mutations in this population.
Selected media mentions
Link to EFE Futuro
Link to La Vanguardia
Link to El Periódico
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
